PPB - Services

Complaints, Feedback and Enquiry

Medicines Quality Alert: Class II Recall of Normnil (Albendazole 400mg) Batch Number 2103104, 2012082, 2007067, 2007098, 2006202, 2006200

The Pharmacy and Poisons Board has initiated a mandatory recall of Normnil (Albendazole 400mg) batches; 2103104, 2012082, 2007067, 2007098, 2006202, 2006200 manufactured by Dawa Life Sciences.

From: Pharmacy and Poisons Board

Published: 11th April 2023

Recall Reference Number: REC/2023/006

Recall Classification: Class II

Recall Level: Retail/Facility level

Manufacturer: Dawa Life Sciences, Kenya

Product name: Normnil

Active Pharmaceutical Ingredient: Albendazole 400mg

Affected counties: All

Affected Batches

Batch Number

Date of Manufacture

Date of expiry

Pack Size

2103104

03/2021

12/2020

500’s

2012082

12/2020

11/2023

500’s

2007067

07/2020

06/2020

500’s

2007098

07/2020

06/2023

100’s

2006202

06/2020

05/2023

500’s

2006200

06/2020

05/2023

500’s

Brief description of the problem

The Pharmacy and Poisons Board has mandated Dawa Life Sciences to initiate an urgent recall of Normnil (Albendazole 400mg) batches; 2103104, 2012082,  2007067, 2007098, 2006202, and 2006200. The product is being recalled following several market complaints on molding, cracking, and change in color. Quality control analysis confirmed discrepancies were observed in the coloration of the tablets, deviating from registered specifications.

Action for healthcare professionals

You are advised to immediately quarantine and stop supplying the remaining stock of impacted batches of the product. Dawa Life Sciences will contact healthcare professionals directly to arrange the return of the products.

Action for patients and carers

Patients who have been prescribed the impacted batches of Normnil (Albendazole 400mg) should seek advice from their healthcare providers. This is because you require a review with your prescribing healthcare professional to discuss alternative treatment options.

Further Information

For stock inquiries please contact Dawa Life Sciences by email at: info@dawalifesciences.com, sales@dawalifesciences.com, or via telephone at +254 733 764 747/20 356 9904

You are advised to promptly report any cases of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:

For any further information please contact the post-marketing surveillance unit at the Pharmacy and Poisons Board by email: pms@ppb.go.ke

Download document

Medicines Quality Alert: Class II Recall of Normnil (Albendazole 400mg) Batch Number 2103104, 2012082, 2007067, 2007098, 2006202, 2006200